Efficacy and safety of carmustine wafers, followed by radiation, temozolomide, and bevacizumab therapy, for newly diagnosed glioblastoma with maximal resection
Efficacy and safety of carmustine wafers, followed by radiation, temozolomide, and bevacizumab therapy, for newly diagnosed glioblastoma with maximal resection
Yukinori Akiyama, Yuichi Hirose, Tatsuya Abé, Yoshiteru Shimoda et al.
Citations
3 citations
Journal
International Journal of Clinical Oncology
Topics
Glioma Diagnosis and Treatment
Field-Weighted Citation Impact (FWCI)
1.31
article
Efficacy and safety of carmustine wafers, followed by radiation, temozolomide, and bevacizumab therapy, for newly diagnosed glioblastoma with maximal resection
International Journal of Clinical OncologyVol. 30(1)
Institutions
Kagoshima University (JP), Yamagata University (JP), Sapporo Medical University (JP), Fujita Health University (JP), Hirosaki University (JP), Okayama University (JP), St. Marianna University School of Medicine (JP), Yamaguchi University (JP), Saga University (JP), Iwate Medical University (JP), Tohoku University (JP), Akita University (JP), Kyoto University (JP), Fukuoka University (JP), Teikyo University Hospital (JP), Miyagi Prefectural Hospital Organization (JP), Sendai Medical Center (JP), National Hospital Organization (JP), University of Houston (US), Nagoya University (JP), Kitasato University (JP), University of Yamanashi (JP), Niigata University (JP), Osaka University of Pharmaceutical Sciences (JP)